FOLH1 and prostate carcinoma: PSMA as folate hydrolase I and glutamate carboxypeptidase II, is a well-known transmembrane protein [10] over expressed on prostate cancer epithelial cells [11], [12] and has been shown to have great potential for prostatic cancer (PCa) therapy.